Search:
Home Index Back issues Contact

This item requires a subscription.

Antiplatelet therapy following oral anticoagulant treatment for VTE
Thrombus, Volume 6, Number 4.

Venous thromboembolism (VTE) is a common and potentially life-threatening problem. The annual incidence of VTE in North American and European populations is about one per 1,000 per year.1,2 Like many disorders the incidence is age-related, ranging from about one in 10,000 per year in young adults (and even less in children) to approaching 1% per year in the elderly. In a Swedish study of men followed prospectively between the ages of 50 and 80, pulmonary embolism was responsible for about 4% of deaths.3

To view this item, select one of the options below:

Purchase access
In order to view articles you will need to pay a subscription for either 24-hour or annual access. You can view all articles on this site during the subscription period.
Please click here to subscribe.
 

Sign in
If you are already have a subscription, please sign in here.

email address

Password
Forgotten your password?

Important

All the articles are in PDF format.

To view the articles you will need Adobe Acrobat Reader.

To download a copy, free of charge,
please click here.
 
Help
  If you need help accessing this site, please click here.


 

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsors, publisher, Editor or Editorial Board. Accordingly the sponsors, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.
Copyright (©) 2010 Hayward Group Ltd. The title Thrombus is the property of Hayward Group Ltd and, together with the content, is bound by copyright. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to: admin@hayward.co.uk